Breaking News, Promotions & Moves

LBB Specialties LLC Appoints CEO

Birkelbach is an industry executive with more than 25 years of experience in specialty chemical distribution

By: Kristin Brooks

Managing Editor, Contract Pharma

LBB Specialties LLC has appointed Darren J. Birkelbach as chief executive officer.



Darren J. Birkelbach
Mr. Birkelbach, who joined LBB Specialties in May 2019 as president, American International Chemical (AIC), will have oversight for all commercial and operational functions across LBB Specialties, including AIC, Charkit, and future acquisitions. Mr. Birkelbach is an industry executive with more than 25 years of experience in specialty chemical distribution, and a successful track record driving business growth in diverse roles that include sales and marketing, operations, and finance.
 
In addition, Jay Lang, formerly president of Charkit, has been promoted to executive vice president, Strategic Business Development for LBB Specialties.  Mr. Lang will lead key commercial growth initiatives for both organizations and play a key role in assessing potential acquisition targets for the LBB Specialties portfolio. 
 
Mr. Hinnant said, “LBB Specialties’ growth strategy will enable AIC and Charkit to offer our customers and principals even stronger partnerships than we can today.  Redeploying our two Presidents to enterprise-wide roles will facilitate strategic alignment to maximize growth, which LBB Specialties is committed to pursuing via the AIC and Charkit brands.” 
 
Mr. Birkelbach said, “LBB Specialties is perfectly positioned for accelerated growth through our focused market coverage, strong relationships with specialty product principals, acquisition strategy, and commitment to provide top-notch service and quality to our growing customer base. I’m excited to begin my expanded role and the opportunity to work alongside the entire team to meet and exceed expectations.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters